glp-1 safe to use Agonist Addiction Treatment Scientists cautiously suggest GLP-1s are

3-4 BPC-157

Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health

MOTS-c has been linked to metabolic and mitochondrial function, which is why it shows up in longevity-focused conversations

Are there any side effects

Why is Ipamorelin preferred over GHRP-2 or GHRP-6